Breaking News Instant updates and real-time market news.

VEEV

Veeva

$41.56

-0.21 (-0.50%)

, GME

GameStop

$24.11

0.65 (2.77%)

18:47
11/22/16
11/22
18:47
11/22/16
18:47

On The Fly: After Hours Movers

UP AFTER EARNINGS: Veeva (VEEV), up 5.15%... GameStop (GME), up 2%... Caleres (CAL), up 1.93%... Mentor Graphics (MENT), up 0.6%. ALSO HIGHER: eGain (EGAN), up 2.2% after IBIM2 reported a 5% passive stake in the company... Take-Two (TTWO), up 1.5% after GameStop reported quarterly earnings above analysts' expectations. DOWN AFTER EARNINGS: Nimble Storage (NMBL), down 10.8%... Urban Outfitters (URBN), down 9.1%... HP Inc. (HPQ), down 2.45%... HP Enterprise (HPE), down 0.9%. ALSO LOWER: Enable Midstream (ENBL), down 10.3% after it filed to sell 10M common units representing limited partners... Baytex Energy (BTE), down 2.4% after it agreed to acquire Alberta heavy oil assets for C$65M.

VEEV

Veeva

$41.56

-0.21 (-0.50%)

GME

GameStop

$24.11

0.65 (2.77%)

CAL

Caleres

$28.45

1.14 (4.17%)

MENT

Mentor Graphics

$36.53

-0.02 (-0.05%)

EGAN

eGain

TTWO

Take-Two

$47.28

-0.75 (-1.56%)

NMBL

Bought by HPE

$9.24

0.15 (1.65%)

URBN

Urban Outfitters

$39.01

1.84 (4.95%)

HPQ

HP Inc.

$15.95

-0.05 (-0.31%)

HPE

HP Enterprise

$22.87

-0.25 (-1.08%)

ENBL

Enable Midstream

$16.09

-0.26 (-1.59%)

BTE

Baytex Energy

$4.10

-0.02 (-0.49%)

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 22

    Nov

  • 28

    Nov

  • 30

    Nov

  • 01

    Dec

  • 02

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

  • 09

    Jan

  • 23

    Nov

VEEV Veeva
$41.56

-0.21 (-0.50%)

10/04/16
GSCO
10/04/16
INITIATION
Target $43
GSCO
Neutral
Veeva initiated with a Neutral at Goldman
Goldman analyst Jesse Hulsing initiated Veeva with a Neutral and a $43 price target due to premium valuation. .
10/03/16
ADAM
10/03/16
NO CHANGE
Target $46
ADAM
Buy
Veeva price target raised to $46 from $43 at Canaccord
Canaccord analyst Richard Davis raised his price target on Veeva to $46 from $43 following its analyst day. The analyst believes Veeva has executed better than expected and expects the execution to continue. Davis reiterated his Buy rating on Veeva shares.
09/30/16
NEED
09/30/16
NO CHANGE
Target $46
NEED
Buy
Veeva price target raised to $46 after analyst day at Needham
Needham analyst Scott Berg said that after attending Veeva's analyst day meeting he believes that enthusiasm for stronger near-term sales opportunities was high. Noting that the company acknowledged it is tracking ahead of its CY20 operating model goals, Berg raised his price target on the stock to $46 from $43 and keeps a Buy rating on Veeva shares.
10/13/16
JMPS
10/13/16
INITIATION
JMPS
Market Perform
Veeva initiated with a Market Perform at JMP Securities
JMP Securities analyst Rishi Jaluria started Veeva with a Market Perform rating.
GME GameStop
$24.11

0.65 (2.77%)

11/02/16
PIPR
11/02/16
DOWNGRADE
Target $23
PIPR
Neutral
GameStop cut to Neutral on game business erosion at Piper Jaffray
As previously reported, Piper Jaffray analyst Michael Olson, downgraded GameStop to Neutral from Overweight after the company pre-released a quarterly earnings miss and lowered its fiscal year guidance. This quarter will "prove to be a microcosm of the next several years," as the company's core gaming business erosion cannot be offset by growth in its new initiatives, predicted Olson, who lowered his price target on GameStop shares to $23 from $41.
11/11/16
PIPR
11/11/16
NO CHANGE
PIPR
Oct. NPD video game software sales rose 11%, says Piper Jaffray
Piper Jaffray analyst Michael Olson says October NPD video game software sales were up 11% year-over-year due to strong results from incremental launch titles, including Electronic Arts' (EA) Battlefield 1 as well as Take Two's (TTWO) Mafia III, among others. The analyst, however, views the October NPD results as "largely irrelevant" since Activision Blizzard (ATVI), EA and Take-Two already announced December quarter guidance and GameStop (GME) recently announced preliminary October quarter results. He keeps Overweight ratings on all four names.
11/03/16
BARD
11/03/16
NO CHANGE
Target $25
BARD
Outperform
GameStop price target lowered to $25 from $40 at Baird
Baird analyst Colin Sebastian lowered his price target on GameStop to $25 from $40 following its Q3 preannouncement. The analyst said his field checks indicated mixed pre-order levels for key holiday titles through October and he expects promotional activity to drive holiday demand. Sebastian maintained his Buy rating on GameStop shares as his rating is based on the company's long-term diversification strategy and ongoing free cash flow generation.
11/02/16
PIPR
11/02/16
DOWNGRADE
PIPR
Neutral
GameStop downgraded to Neutral from Overweight at Piper Jaffray
CAL Caleres
$28.45

1.14 (4.17%)

02/25/16
BUCK
02/25/16
UPGRADE
BUCK
Buy
Caleres upgraded to Buy from Neutral at Buckingham
01/27/16
01/27/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Arista Networks (ANET) initiated with a Buy at Citi... Brocade (BRCD) initiated with a Neutral at Citi... CBL & Associates (CBL) initiated with an Underperform at Boenning & Scattergood... Caleres (CAL) initiated with a Hold at BB&T... Ciena (CIEN) initiated with a Neutral at Citi... Fitbit (FIT) initiated with a Buy, $35 target at Citi... Genesco (GCO) initiated with a Hold at BB&T... Infinera (INFN) initiated with a Buy at Citi... Nabriva Therapeutics (NBRV) initiated with a Buy at Gabelli... SanDisk (SNDK) initiated with a Buy at Citi... Seagate (STX) initiated with a Sell at Citi... Tanger Factory (SKT) initiated with an Underperform at Boenning & Scattergood... Taubman Centers (TCO) initiated with a Neutral at Boenning & Scattergood... WP Glimcher (WPG) initiated with an Underperform at Boenning & Scattergood... Western Digital (WDC) initiated with a Buy at Citi... Yirendai (YRD) initiated with a Buy at Needham.
05/27/16
05/27/16
UPGRADE
Target $26

Buy
Caleres upgraded to Buy from Hold at BB&T
BB&T analyst Corinna Freedman upgraded Caleres due to valuation following the Q1 report and established a $26 price target on shares.
01/27/16
01/27/16
INITIATION

Hold
Caleres initiated with a Hold at BB&T
MENT Mentor Graphics
$36.53

-0.02 (-0.05%)

10/27/16
10/27/16
NO CHANGE

Mentor Graphics partners with Telemotive on vehicle smart charging technology
Mentor Graphics (MENT) announced a joint engineering and marketing agreement with Telemotive AG, a Magna (MGA) company and an automotive supplier of engineering services and tech products. The heart of the agreement will be the integration of Mentor's Volcano VSTAR AUTOSAR stack with Telemotive's Power Line Communication creating electronic control units that allow for smart charging of electric vehicles.
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded to Buy from Neutral at DA Davidson
10/10/16
DADA
10/10/16
UPGRADE
DADA
Buy
Mentor Graphics upgraded on multiple catalysts at DA Davidson
As noted earlier, DA Davidson upgraded Mentor Graphics to Buy from Neutral. Analyst Thomas Diffely says that the company is benefiting from multiple catalysts, including exposure to vertical markets that will enable multi-year growth, solid cash flow, and an activist investor that can help the company unlock value. He thinks that the company can benefit by optimizing its operations, and he finds the stock's valuation attractive. Target to $32 from $24.
10/19/16
FBCO
10/19/16
INITIATION
Target $34
FBCO
Outperform
Mentor Graphics initiated with an Outperform at Credit Suisse
Credit Suisse analyst Farhan Ahmad initiated Mentor Graphics with an Outperform and a $34 price target. The analyst believes the Street is underestimating Mentor's growth and sees potential for multiple expansion as the company starts to deliver. Additionally, Ahmad said Mentor screens well as a potential target for for Systems Design Software companies given the increasing importance of EDA companies in systems design.
EGAN eGain

09/09/16
LTCO
09/09/16
UPGRADE
Target $3.75
LTCO
Buy
eGain upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Jon Hickman upgraded eGain to Buy citing the recent pullback in the shares. The analyst keeps a $3.75 price target for the stock following eGain's Q4 results.
05/09/16
LTCO
05/09/16
DOWNGRADE
Target $3.75
LTCO
Neutral
eGain downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst Jon Hickman downgraded eGain to Neutral saying the company's transition to a SaaS model is more disruptive to revenue growth than expected. The analyst cut his price target for the shares to $3.75 from $7.50 following the company's Q3 results.
11/10/16
LTCO
11/10/16
DOWNGRADE
Target $2.3
LTCO
Neutral
eGain downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst Jon Hickman downgraded eGain to Neutral saying the company's Q1 results indicate its transition to a SaaS model is more disruptive to revenue growth than anticipated. The analyst lowered his price target for the shares to $2.30 from $3.75.
TTWO Take-Two
$47.28

-0.75 (-1.56%)

10/14/16
PIPR
10/14/16
NO CHANGE
PIPR
Sept. NPD video game software sales fell 31%, says Piper Jaffray
Piper Jaffray analyst Michael Olson notes September NPD video game software sales fell 31% year-over-year amid a tough comparison with launches last year of Konami's Metal Gear Solid V and Nintendo's Super Mario Maker. Top sellers this year were Take-Two's (TTWO) NBA 2K17 and Electronic Arts' (EA) Madden NFL 17 and FIFA, Olson tells investors in a research note. He views Take-Two as the biggest winner for the full September quarter. The analyst keeps Overweight ratings on Take-Two, EA, Activision Blizzard (ATVI) and GameStop (GME).
10/13/16
OPCO
10/13/16
INITIATION
Target $54
OPCO
Outperform
Take-Two initiated with an Outperform at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz initiated Take-Two Interactive with an Outperform rating and $54 price target as he believes the smallest of the three video game publishers publicly listed in the U.S. is well positioned for revenue and earnings growth.
10/18/16
PIPR
10/18/16
NO CHANGE
Target $51
PIPR
Overweight
Red Dead 2 timing in-line with expectations, says Piper Jaffray
Piper Jaffray analyst Michael Olson noted that Take-Two confirmed that Red Dead Redemption 2 will ship in Fall 2017 following two days of hinting at an announcement. The timing is in-line with his expectations, said Olson, who added that 23% of the 450 console owners surveyed by the firm said they expect to buy the game, which he estimates would translate to about 17M units sold. Olson keeps an Overweight rating and $51 price target on Take-Two shares.
NMBL Bought by HPE
$9.24

0.15 (1.65%)

09/01/16
PACS
09/01/16
NO CHANGE
PACS
Nimble Storage seeing larger deals, says Pacific Crest
After meeting with Nimble's CFO, Pacific Crest analyst Alex Kurtz says that the company is " driving larger deals into the pipeline with the newly launched All Flash Array platforms." He says that these larger deals were probably not baked into its guidance. The analyst keeps a Sector Weight rating on the shares.
10/03/16
SUSQ
10/03/16
NO CHANGE
Target $12
SUSQ
Positive
Nimble Storage well positioned to gain market share, says Susquehanna
Susquehanna analyst Mehdi Hosseini believes Nimble Storage remains well positioned to continue to gain market share with its dual faceted approach and material operating leverage on the horizon in 2018. Hosseini reiterated his Positive rating and $12 price target on Nimble Storage shares.
08/24/16
JPMS
08/24/16
NO CHANGE
Target $9.5
JPMS
Neutral
Nimble Storage momentum in Flash picking up, says JPMorgan
JPMorgan analyst Rod Hall said that the momentum in Nimble Storage's Flash business and international operations has picked up, but noted that the company's operating margin guidance came in a bit below his estimate. Hall raised his price target on Nimble shares to $9.50 from $8.00 following the company's earnings report, but keeps a Neutral rating on shares, saying he'd like to see a clear road to profitability before getting more constructive.
09/29/16
WELS
09/29/16
UPGRADE
WELS
Outperform
Nimble Storage upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Maynard Um upgraded Nimble Storage to Outperform saying the risk/reward is favorable at current valuation levels. A "strong pipeline" for Nimble's all-flash array should drive revenue acceleration in FY18 and multiple expansion, Um tells investors in a research note. The analyst raised his price target range for the shares to $10-$11 from $9-$10.
URBN Urban Outfitters
$39.01

1.84 (4.95%)

11/17/16
MSCO
11/17/16
DOWNGRADE
MSCO
Equal Weight
Urban Outfitters downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger downgraded Urban Outfitters to Equal Weight and raised its price target to $39 citing year-to-date share strength and more balanced risk/reward.
11/10/16
WDLK
11/10/16
UPGRADE
Target $40
WDLK
Buy
Urban Outfitters upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Eric Beder upgraded Urban Outfitters to Buy and raised his price target for the shares to $40 from $31.
10/24/16
JEFF
10/24/16
NO CHANGE
Target $45
JEFF
Buy
Jefferies sees margin potential as another reason to buy Urban
Jefferies analyst Randal Konik views underappreciated margin expansion as another reason to own shares of Urban Outfitters. Margins at the namesake store and Anthropologie are "well off highs" and can improve 500 basis points over the next few years, Konik tells investors in a research note. He keeps a Buy rating on Urban Outfitters with a $45 price target.
09/07/16
WOLF
09/07/16
UPGRADE
Target $43
WOLF
Outperform
Urban Outfitters upgraded to Outperform from Peer Perform at Wolfe Research
Wolfe upgraded Urban Outfitters to Outperform with a $43 price target citing share gains, improving fundamentals, sustained promotional discipline, and sustained positive comps.
HPQ HP Inc.
$15.95

-0.05 (-0.31%)

08/25/16
MAXM
08/25/16
DOWNGRADE
Target $15
MAXM
Hold
HP Inc. downgraded to Hold on pressured printing margins at Maxim
As previously reported, Maxim analyst Nehal Chokshi downgraded HP Inc. to Hold from Buy and lowered his price target to $15 from $17, saying that his analysis points to sustained printing supplies pricing pressure despite the refresh of its printer hardware. Chokshi added that he expects the company to lower its FY17 earnings guidance at its Securities Analyst Meeting in October.
08/25/16
EVER
08/25/16
NO CHANGE
EVER
Micron has positive read through from HP statements, says Evercore ISI
After Hewlett-Packard (HPQ) said, "We are seeing on the horizon some shortages, particularly around LCDs, DRAM, and flash memory.," Evercore ISI analyst C.J. Muse says that the statement is positive for Micron. The analyst keeps a $16 price target and Buy rating on Micron.
08/25/16
MAXM
08/25/16
DOWNGRADE
MAXM
Hold
HP Inc. downgraded to Hold from Buy at Maxim
10/14/16
BMUR
10/14/16
NO CHANGE
Target $18
BMUR
Buy
HP Inc. new business model conservative, says Brean Capital
Brean Capital analyst Ananda Baruah attended the HP, Inc. analyst day and said although it didn't hold any surprises, he believes the company's new long-term business model remains conservative. The analyst said if the company can execute its model its revenue growth will have to be stronger than stated and its guidance must be conservative. Baruah reiterated his Buy rating and $18 price target on HP, Inc. shares.
HPE HP Enterprise
$22.87

-0.25 (-1.08%)

11/18/16
11/18/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold saying he believes the spinoff of its Enterprise Service and Software businesses will unlock value and said checks have been positively biased in North American enterprises and Federal verticals. 2. Exelon (EXC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Stephen Byrd saying Exelon offers attractive growth at a compelling valuation with meaningful ROE improvement at acquired utilities. 3. Goldman Sachs (GS) upgraded to Outperform from Neutral at Macquarie with saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. 4. Hain Celestial (HAIN) upgraded to Neutral from Underperform at BofA/Merrill and to Neutral from Underweight at Atlantic Equities. 5. FleetCor (FLT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Timothy Willi saying the 13% selloff since the company's third quarter results on November 1 is overdone and presents a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
11/18/16
UPGRADE
Target $29

Outperform
HP Enterprise upgraded to Outperform ahead of spinoff at Raymond James
As previously reported, Raymond James upgraded HP Enterprise to Outperform from Market Perform with a $29 price target. Analyst Simon Leopold believes spinoff of its Enterprise Service and Software businesses will unlock value and said checks have been positively biased in North American enterprises and Federal verticals. The analyst said the rating change is not a call on the quarter and expects results to be largely in line when the company reports on November 22.
11/18/16
RAJA
11/18/16
UPGRADE
RAJA
Outperform
HP Enterprise upgraded to Outperform from Market Perform at Raymond James
10/19/16
OPCO
10/19/16
NO CHANGE
Target $25
OPCO
Outperform
Oppenheimer remains bullish on HP Enterprise with spinoffs on track
After attending the company's investor day, Oppenheimer analyst Ittai Kidron says he remains bullish on HP Enterprise's story and sees upside as the spinoffs close and value is unlocked. Additionally, the analyst believes the Enterprise Group offers both growth and margin expansion opportunities, and the free cash flow characteristics of the company are attractive and suggest residual HP Enterprise valuation is depressed. Kidron reiterates an Outperform rating and $25 price target on the shares.
ENBL Enable Midstream
$16.09

-0.26 (-1.59%)

10/07/16
WOLF
10/07/16
INITIATION
WOLF
Peer Perform
Enable Midstream initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Steven Fleishman initiated Enable Midstream with a Peer Perform and a $16 price target.
09/19/16
GSCO
09/19/16
UPGRADE
GSCO
Neutral
Enable Midstream upgraded to Neutral from Sell at Goldman
Goldman analyst Theodore Durbin upgraded Enable Midstream citing more balanced risk/reward. The analyst raised his price target to $24 from $20 on shares.
09/13/16
FBCO
09/13/16
DOWNGRADE
Target $16
FBCO
Neutral
Enable Midstream downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst John Edwards downgraded Enable Midstream to Neutral citing year-to-date share strength and maintained its $16 price target.
08/08/16
RBCM
08/08/16
NO CHANGE
RBCM
CenterPoint Energy weakness overdone, says RBC Capital
RBC Capital analyst Insoo Kim says that Centerpoint's (CNP) stock may have fallen Friday due to the company's weaker than expected results and its decision not to pursue a REIT structure. The analyst remains upbeat on the company's outlook in the absence of a REIT conversion. Kim continues to believe that Centerpoint's potential sale or spin of its Enable Midstream (ENBL) stake is a positive catalyst for it. Kim keeps a $26 price target and Outperform rating on the shares.
BTE Baytex Energy
$4.10

-0.02 (-0.49%)

06/30/16
BMOC
06/30/16
UPGRADE
BMOC
Market Perform
Baytex Energy upgraded to Market Perform from Underperform at BMO Capital
12/07/15
RBCM
12/07/15
INITIATION
Target $8
RBCM
Sector Perform
Baytex Energy initiated with a Sector Perform at RBC Capital
RBC Capital analyst Greg Pardy initiated Baytex Energy with a Sector Perform and $8 price target on shares.
01/15/16
BMOC
01/15/16
NO CHANGE
BMOC
Baytex Energy coverage assumed with an Underperform at BMO Capital

TODAY'S FREE FLY STORIES

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/25/17
06/25
04:55
06/25/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/25/17
06/25
04:55
06/25/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

AAPL

Apple

$146.28

0.65 (0.45%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

13:47
06/24/17
06/24
13:47
06/24/17
13:47
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$146.28

0.65 (0.45%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

GOOG

Alphabet

$965.59

8.5 (0.89%)

MSFT

Microsoft

$71.21

0.95 (1.35%)

IBM

IBM

$154.11

-0.29 (-0.19%)

MA

MasterCard

$124.01

0.71 (0.58%)

ORCL

Oracle

$50.95

0.65 (1.29%)

VMW

VMware

$90.92

0.48 (0.53%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AKAM

Akamai

$51.30

1.28 (2.56%)

SAP

SAP

$107.48

0.42 (0.39%)

QCOM

Qualcomm

$56.91

0.44 (0.78%)

ADBE

Adobe

$145.41

1.72 (1.20%)

ACN

Accenture

$122.74

0.66 (0.54%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

CYH

Community Health

$9.33

0.06 (0.65%)

THC

Tenet

$18.52

-0.38 (-2.01%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

UHS

Universal Health

$115.43

0.22 (0.19%)

AET

Aetna

$152.10

-0.88 (-0.58%)

WCG

WellCare

$183.28

-0.32 (-0.17%)

CI

Cigna

$169.61

-1.07 (-0.63%)

HUM

Humana

$238.42

1.42 (0.60%)

ANTM

Anthem

$190.17

-3.19 (-1.65%)

HNT

Health Net

CNC

Centene

$84.15

1.15 (1.39%)

MOH

Molina Healthcare

$71.33

0.02 (0.03%)

UNH

UnitedHealth

$185.25

-1.25 (-0.67%)

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

X

U.S. Steel

$22.25

1.18 (5.60%)

AKS

AK Steel

$6.65

0.35 (5.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 06

    Jul

  • 12

    Jul

  • 13

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 20

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 02

    Aug

  • 14

    Aug

  • 23

    Oct

  • 03

    Feb

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

HIMX

Himax

$8.17

-0.02 (-0.24%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
Himax management to meet with Roth Captial »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

ANTM

Anthem

$190.17

-3.19 (-1.65%)

18:58
06/23/17
06/23
18:58
06/23/17
18:58
Periodicals
Anthem to pay $115M to settle data breach lawsuits, Reuters reports »

Anthem has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVU

Supervalu

$2.94

-0.04 (-1.34%)

18:26
06/23/17
06/23
18:26
06/23/17
18:26
Hot Stocks
Supervalu completes acquisition of Unified Grocers »

Supervalu announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$70.52

0.04 (0.06%)

18:14
06/23/17
06/23
18:14
06/23/17
18:14
Periodicals
Gilead no longer a 'value trap,' Barron's reports »

Consistent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

, EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

18:07
06/23/17
06/23
18:07
06/23/17
18:07
Hot Stocks
Southern National Bancorp, Eastern Virginia Bankshares complete merger »

Southern National Bancorp…

SONA

Southern National Bancorp

$17.21

0.11 (0.64%)

EVBS

Eastern Virginia Bankshares

$11.01

0.14 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IAC

IAC

$104.84

0.3 (0.29%)

17:56
06/23/17
06/23
17:56
06/23/17
17:56
Hot Stocks
IAC will not pursue plan to create new class of non-voting stock »

IAC's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGL

Engility

$27.37

0.26 (0.96%)

17:50
06/23/17
06/23
17:50
06/23/17
17:50
Hot Stocks
Engility to eliminate position of president, COO »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

ADM

Archer Daniels

$41.16

0.13 (0.32%)

17:48
06/23/17
06/23
17:48
06/23/17
17:48
Hot Stocks
ADM Animal Nutrition recalls Rough-N-Ready cattle feed over monensin concerns »

ADM Animal Nutrition, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOYA

Voya Financial

$35.24

0.03 (0.09%)

17:30
06/23/17
06/23
17:30
06/23/17
17:30
Syndicate
Breaking Syndicate news story on Voya Financial »

Voya Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

, TBK

Triumph Bancorp

17:19
06/23/17
06/23
17:19
06/23/17
17:19
Hot Stocks
Independent Bank to sell nine Colorado branches to TBK Bank »

Independent Bank (IBTX)…

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

TBK

Triumph Bancorp

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

WUBA

58.com

$43.30

0.87 (2.05%)

17:11
06/23/17
06/23
17:11
06/23/17
17:11
Hot Stocks
Breaking Hot Stocks news story on 58.com »

General Atlantic reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

, LGF.B

Lionsgate

$25.38

0.34 (1.36%)

17:10
06/23/17
06/23
17:10
06/23/17
17:10
Hot Stocks
Box Office Battle: 'Transformers' expected to top 'Cars 3,' 'Wonder Woman' »

Viacom (VIA, VIAB)…

FOXA

21st Century Fox

$27.19

0.22 (0.82%)

LGF.B

Lionsgate

$25.38

0.34 (1.36%)

DIS

Disney

$104.36

0.14 (0.13%)

VIAB

Viacom

$34.11

-0.01 (-0.03%)

LGF.A

Lionsgate

$27.07

0.31 (1.16%)

VIA

Viacom

$39.15

0.1 (0.26%)

SNE

Sony

$38.52

0.11 (0.29%)

FOX

21st Century Fox

$26.93

0.3 (1.13%)

TWX

Time Warner

$99.70

0.3 (0.30%)

CMCSA

Comcast

$39.50

-0.44 (-1.10%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

  • 03

    Aug

  • 08

    Aug

NVUS

Novus Therapeutics

$6.00

-0.04 (-0.66%)

17:07
06/23/17
06/23
17:07
06/23/17
17:07
Syndicate
Breaking Syndicate news story on Novus Therapeutics  »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXG

Interpace Diagnostics

$0.88

0.03 (3.53%)

17:05
06/23/17
06/23
17:05
06/23/17
17:05
Hot Stocks
Breaking Hot Stocks news story on Interpace Diagnostics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNR

Monmouth Real Estate

$14.95

0.26 (1.77%)

17:02
06/23/17
06/23
17:02
06/23/17
17:02
Hot Stocks
Monmouth Real Estate acquires building in Texas for $50.6M »

Monmouth Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

ARCW

ARC Group

$3.55

0.15 (4.41%)

17:01
06/23/17
06/23
17:01
06/23/17
17:01
Hot Stocks
ARC Group names Drew Kelley as Interim CEO, effective July 1 »

ARC Group Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$4.41

-0.08 (-1.78%)

16:55
06/23/17
06/23
16:55
06/23/17
16:55
Syndicate
PAVmed announces effectiveness of Form S-1 resale registration statement »

PAVmed announced that on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MFSF

MutualFirst Financial

$36.15

0.9 (2.55%)

16:48
06/23/17
06/23
16:48
06/23/17
16:48
Hot Stocks
MutualFirst Financial senior executives enter 10b5-1 trading plans »

On June 23, David Heeter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$32.10

0.25 (0.78%)

16:46
06/23/17
06/23
16:46
06/23/17
16:46
Hot Stocks
Cisco CEO Charles Robbins enters 10b5-1 trading plan »

On June 21, Charles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SITO

SITO Mobile

$3.66

0.02 (0.55%)

16:43
06/23/17
06/23
16:43
06/23/17
16:43
Hot Stocks
SITO Mobile chairman Paul Pressler resigns »

Effective as of June 23,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$517.33

-9.2 (-1.75%)

, CELG

Celgene

$134.31

0.63 (0.47%)

16:41
06/23/17
06/23
16:41
06/23/17
16:41
General news
S&P sees mild weekly gain, Nasdaq outperforms as biotech shines »

The S&P finished the…

REGN

Regeneron

$517.33

-9.2 (-1.75%)

CELG

Celgene

$134.31

0.63 (0.47%)

GILD

Gilead

$70.54

0.06 (0.09%)

BIIB

Biogen

$280.32

-0.25 (-0.09%)

VRTX

Vertex

$133.50

-2.03 (-1.50%)

AMGN

Amgen

$172.50

-1.32 (-0.76%)

ABBV

AbbVie

$72.64

-0.54 (-0.74%)

ALXN

Alexion

$126.07

-0.16 (-0.13%)

BA

Boeing

$202.23

2.79 (1.40%)

ORCL

Oracle

$50.95

0.65 (1.29%)

EQT

EQT Corporation

$56.19

4.16 (8.00%)

RICE

Rice Energy

$25.65

1.62 (6.74%)

SYK

Stryker

$141.12

-0.1 (-0.07%)

NVDQ

Novadaq

$11.78

-0.02 (-0.17%)

PRXL

Parexel

$86.80

-0.31 (-0.36%)

LH

LabCorp

$151.62

1.28 (0.85%)

ICLR

ICON plc

$96.37

-0.26 (-0.27%)

NKE

Nike

$52.85

0.45 (0.86%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

INTC

Intel

$34.19

-0.17 (-0.49%)

AMD

AMD

$14.15

-0.23 (-1.60%)

LZB

La-Z-Boy

$32.30

0.7 (2.22%)

RHT

Red Hat

$99.42

0.54 (0.55%)

AAL

American Airlines

$48.63

-0.34 (-0.69%)

HCA

HCA Holdings

$86.24

0.1 (0.12%)

LPNT

LifePoint

$65.50

-1.6 (-2.38%)

THC

Tenet

$18.52

-0.38 (-2.01%)

SCS

Steelcase

$13.65

-0.45 (-3.19%)

ACN

Accenture

$122.74

0.66 (0.54%)

BBBY

Bed Bath & Beyond

$29.65

-4.09 (-12.12%)

BBRY

BlackBerry

$9.71

-1.35 (-12.21%)

BAC

Bank of America

$22.82

-0.11 (-0.48%)

C

Citi

$63.41

-0.21 (-0.33%)

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

JPM

JPMorgan

$86.86

-0.16 (-0.18%)

MS

Morgan Stanley

$43.69

-0.92 (-2.06%)

WFC

Wells Fargo

$52.45

-0.04 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 23

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 07

    Jul

  • 13

    Jul

  • 14

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

  • 29

    Aug

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 23

    Oct

  • 14

    Nov

  • 15

    Jan

  • 03

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.